Why so many people believe repositioning always comes back
"Doesn't the fat just come back?" is one of the most common questions ST hears — and the frequency itself says something. Many people asking have either experienced a recurrence or read plenty of accounts of one. Here is what two decades of revision surgery has shown: a striking number of patients who arrive saying "I had fat repositioning and it recurred" turn out, once surgery begins, to have had little or no actual repositioning. The fat was never moved and fixed, and the tear-trough band was still attached exactly where it always was. The patient has no way of knowing this from outside — they were told they had repositioning, so when the bags returned, the natural conclusion was that repositioning does not last. The reputation for recurrence largely belongs to surgeries that carry the name without the substance.
What actually holds the fat down: five points on the bone
The lower eyelid holds fat in three compartments — medial, central, and lateral — and a repositioning that intends to last has to account for all three. In the traditional method, whether the approach is through the conjunctiva or through a skin incision, each compartment is exposed and the fat is brought down over the orbital rim and fixed directly to the periosteum, the membrane on the bone along the tear trough. The central compartment is the largest and typically takes two to three fixation points; the medial and lateral compartments take one to two each — a minimum of five points in total, spread evenly so no single compartment is left to drift. The suture material matters too: fixation that relies on one or two points of dissolvable thread gives the fat both time and opportunity to migrate back up. ST uses non-dissolvable sutures for the fat fixation, and then re-fixes the orbital septum over it as a second layer of security. Of the two, the fat fixation itself is the one that most determines whether the result holds.
The ligament that decides whether the groove disappears
Fixation is only half of prevention. Before the fat can settle into the tear trough, the tear-trough band — the ligamentous attachment that pins the groove to the bone — has to be released. If fat is repositioned over an unreleased band, the band stays adherent above the new fat and the groove line simply remains, or reappears as soon as early swelling subsides. To the patient this reads as a failure or a recurrence, but structurally it is something else: the surgery never addressed the anchor that was creating the line. Releasing the band and then fixing the fat below it is what allows the groove to actually flatten — and it is one of the technically demanding steps that simplified versions of this surgery tend to skip.
When there is not enough fat: balancing with a graft
Sometimes the orbital fat available for repositioning is simply not enough to fill the trough. If the surgeon repositions what exists and stops there, the under-eye can still look depleted — and months later the patient reasonably wonders whether the surgery "wore off." Nothing recurred; the volume budget was short from the start. In these cases ST performs fat grafting in the same operation, placing finely processed fat to balance the areas the repositioned fat cannot reach. Whether recurrence is prevented is not only a question of fixation strength — it is also a question of whether the surgical plan honestly matched the amount of tissue available.
Loose skin is not recurrence
A useful analogy: after childbirth, a mother looks slim in clothes, but the skin of the abdomen may still be lax — the volume that stretched it has moved, and skin with reduced elasticity does not fully snap back. The under-eye behaves the same way. The bulging fat that was pushing the skin outward has been relocated downward, and in patients whose skin and muscle tone were already reduced, the overlying skin can look slightly loose afterward. Patients sometimes read this as the surgery failing or the bags returning. It is neither — the fat is where it was placed. The skin laxity itself was always there, previously masked by the bulge, and when it bothers the patient it is addressed with a comparatively minor skin-muscle tightening, not with another repositioning.
What true recurrence looks like — and the honest limits
True recurrence has recognizable forms: the bulge itself protrudes again; the tear trough becomes deeper than it was — which is worse than recurrence, it is deterioration; or by around the two-month mark, once the first month of swelling has settled, the under-eye looks essentially unchanged from before surgery. Judging any of this in the first month is premature, because swelling flatters the result. And one honest boundary: nothing in the aging face is permanent. The eye keeps aging, and repositioning resets the under-eye rather than freezing it. What can be said is this — fat that has been moved with its blood supply intact and fixed securely at five points does not need to be repositioned again. That is what ST means by calling the result semi-permanent, and it is why the recurrence question is really a question about how the first surgery was done.